The U.S. 2nd Court of Appeals recently revisited a whistleblower lawsuit against Novartis, a Swiss pharmaceutical company, creating a new development in the enforcement of the Anti-Kickback Statute, Policy & Medicine reported Jan. 8.
Anti-Kickback Statute grows in scope: 5 things to know
